MTOR and carcinoma: In the current review, we describe the critical role of the PI3K/AKT/mTOR and RAF/MEK/ERK signaling pathways in carcinoma initiation and tumor development as potential strategies for tumor therapy, summarizing the recent doubts about targeting the pathway in monotherapy and combination therapy.